Mead Johnson
BMS profits buoyant after Mead Johnson jettisoned
February 1, 2010Sales and Marketing 2009 financials, BMS, Mead Johnson
Bristol-Myers Squibb’s have revealed continued strong sales of the anti-blood clotting treatment Plavix and the antipsychotic Abilify and a huge …
Latest content
Medtronic secures CE Mark for new cardiac pacing portfolio
October 30, 2026
Dermatology leader Doncker is new Onicor CEO
October 29, 2026
October 28, 2026
